Conway Robert E's Form 4 filing
Alpine Immune Sciences, Inc. (ALPN) · filed Sep 24, 2021
- Accession no.
- 0001626199-21-000127
- Filed
- Sep 24, 2021
- Trade date
- Sep 23, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $151.2K. It was filed 1 day after the trade.
This filing was later replaced by the amendment 0001626199-21-000130 (Sep 27, 2021). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Conway Robert ECIK 0001184334 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2021 | Common Stock | SSaleAcquired | +15,000 | $10.08F1 | +$151,200 | 50,000 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
(1)This transaction was executed in multiple trades at prices ranging from $9.945 to $10.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.